BDBM326327 3-[4-(5-chloropyridin-3- yl)-5-[(trans-4- methylcyclohexyl)methyl]- 7-(pyridin-3-ylmethyl)-5H- pyrrolo[3,2-d]pyrimidin-2- yl]-1,2,4-oxadiazol-5(4H)- one::US9637493, 7.1

SMILES C[C@H]1CC[C@H](Cn2cc(Cc3cccnc3)c3nc(nc(-c4cncc(Cl)c4)c23)-c2noc(=O)[nH]2)CC1

InChI Key

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 326327   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM326327(3-[4-(5-chloropyridin-3- yl)-5-[(trans-4- methylcy...)
Affinity DataIC50:  52nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent